Conference - London, United Kingdom
The development of the biosimilars market is growing exponentially with the industry forecast to be worth $25 billion by 2020. With the regulatory landscape evolving rapidly, it is important to understand the developments in the biosimilar guideline framework and the cohesion in legislation between Europe and the US.
With Europe leading the way in the field of biosimilar development, it is important to get to grips with all areas in the product lifecycle from early stage developments, protein characterisation and analytical comparability to patent litigation, market access, pricing and reimbursement through to emerging markets and global developments. Every angle should be considered and taken account for through the development process and with the EU the most advanced market for biosimilars, accounting for 80% of global spending on these molecules, the learning curve for biosimilars is essentially still building and there are hurdles to overcome.
Unlocking the potential of biosimilars will require a focused strategy along the whole value chain, from optimising the clinical development programme through developing the most suitable strategy for commercialisation.
Against this backdrop, SMi's 6th annual Biosimilars and Biobetters conference will feature sessions on areas including product lifecycle from early stage developments, protein characterisation and analytical comparability to patent litigation, market access, pricing and reimbursement through to emerging markets and global developments.
- Organization: SMi Group
Wed, Sep 30, 2015 - Thu, Oct 01, 2015
Holiday Inn Kensington Forum
97 Cromwell Road, SW7 4DN, London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.